Jaramillo JL, Martínez SLM, Rodríguez GMDLÁ, Gaviria GJR, Jaramillo MMC, Urrego VA, Ospina SJP, Hernández SJM, Martínez DGI

Language: Spanish
References: 11
Page: 76-81
PDF size: 151.32 Kb.

ABSTRACT

Introduction. Community-acquired pneumonia (CAP) is one of the leading causes of death due to infection.
Objective. To determine the compliance to clinical practice guidelines for cap in a high level medical institution.
Methods and Materials. descriptive retrospective study, which included patients with a diagnosis of CAP. An instrument was designed for collecting data, likewise the CURB-65 scale was used for assessing the severity of pneumonia.
Results. 522 medical records of patients with cap were analyzed, the average age was 66.5 ± 19.4 years old, and females were predominant. The most frequent comorbidities were cardiopulmonary disease 65.7%, smoking 26.6% and alcoholism 7.3%. The curb-65 score was applied only in 11.5% of patients, 64.4% received treatment in hospital general ward, 6.7% in ICU and 28.9% as outpatients; in 68% of patients was used one of the indicated therapies, the doses were correct in 90.7% but only 62.9% for correct time.
Discussion. The levels of adherence to treatment guidelines show low compliance with established protocols. It is advisable to follow the guidelines established by the institutions for the treatment of diseases such as CAP, because they are made based on scientific evidence, local microbiological profile and seek to reduce morbidity and mortality associated with these diseases.

REFERENCES

1. Serisier, D.J., Williams, S. y Bowler, S.D., “Australasian respiratory and emergency physicians do not use the pneumonia severity index in community-acquired pneumonia”, Respirology, 2013, 18 (2):291-296.

2. Julián-Jiménez, A., Palomo de los Reyes, M.J., Parejo Miguez, R., Laín-Terés, N., Cuena-Boy, R. y Lozano-Ancín, A., “Improved management of community-acquired pneumonia in the emergency department”, Arch Bronconeumol, 2013, 49 (6): 230-240.

3. Mocelin, C.A. y Pires dos Santos, R., “Community-acquired pneumonia at the Hospital de Clínicas de Porto Alegre: evaluation of a care protocol”, Braz J Infect Dis, 2013, 17 (5): 511-515.

4. Montúfar, F.E., Varón, F.A., Giraldo, L.F., Sáenz, Ó.A., Rodríguez, A., Alarcón, A.M. et al., “Recomendaciones para el diagnóstico, tratamiento y prevención de la neumonía adquirida en la comunidad en adultos inmunocompetentes”, Infectio Rev de la Asociación Colombiana de Infectologia, 2013, 17 (1S): 1-38.

5. Lim, W.S., Van der Eerden, M.M., Laing, R., Boersma, W.G., Karalus, N., Town, G.I. et al., “Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study”, Thorax, 2003, 58 (5): 377-382.

6. Levy, G., Pérez, M., Rodríguez, B., Hernández Voth, A., Pérez, J., Gnoni, M. et al., “Adherence with national guidelines in hospitalized patients with community-acquired pneumonia: results from the capo study in Venezuela”, Arch Bronconeumol, 2015, 51 (4): 163-168.

7. Salluh, J.I., Lisboa, T., Bozza, F.A., Soares, M. y Póvoa, P., “Management of severe community-acquired pneumonia: a survey on the attitudes of 468 physicians in Iberia and South America”, J Crit Care, 2014, 29 (5): 743-747.

8. British Thoracic Society Standards of Care Committee, “bts Guidelines for the Management of Community Acquired Pneumonia in Adults”, Thorax, 2001, 56 (Suppl 4): 1-64.

9. Ministerio de Salud, Resolución No. 008430, octubre 4 de 1993, Capítulo 1. De los aspectos éticos de la investigación en seres humanos. Artículo 11, Numeral b.

10. Frei, C.R., Attridge, R.T., Mortensen, E.M., Restrepo, M.I., Yu, Y., Oramasionwu, C.U., Ruiz, J.L. y Burgess, D.S., “Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit”, Clin Ther, 2010, 32 (2): 293-299.

11. Jamal, M. y Majed, M., “Evaluation of hospital admission criteria for community acquired-pneumonia patients at a private hospital in uae”, J Pharm Res, 2013, 7 (4): 267-270.